Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Moderna Inc MRNA

Healthcare Biotechnology

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more

Add To Watchlist

Recent & Breaking News (NDAQ:MRNA)

Moderna Announces New Supply Agreement with the Philippines for 7 Million Additional Doses of COVID-19 Vaccine Moderna

Business Wire March 22, 2021

Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population

Business Wire March 16, 2021

First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna's Next Generation COVID-19 Vaccine

Business Wire March 15, 2021

Dr. Elizabeth Nabel Rejoins Moderna's Board of Directors

Business Wire March 10, 2021

Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates

Business Wire March 10, 2021

Moderna Named Fast Company's Most Innovative Company for 2021

Business Wire March 9, 2021

Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Business Wire March 8, 2021

Shannon Thyme Klinger Joins Moderna as Chief Legal Officer and Corporate Secretary

Business Wire March 8, 2021

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Business Wire March 6, 2021

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna's COVID-19 Vaccine Candidate in Japan

Business Wire March 5, 2021

Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing

PR Newswire March 4, 2021

Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target

PR Newswire February 25, 2021

Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates

Business Wire February 25, 2021

Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine

Business Wire February 24, 2021

Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Study

Business Wire February 24, 2021

Moderna to Present at Upcoming Investor Conferences in February and March 2021

Business Wire February 18, 2021

Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us

Livemoney February 17, 2021

European Commission Purchases Additional 150 Million Doses of COVID-19 Vaccine Moderna

Business Wire February 17, 2021

The Benefits of Moringa Could be Used in the Pandemic Fight

Livemoney February 17, 2021

Moderna Provides U.S. COVID-19 Vaccine Supply Update

Business Wire February 16, 2021